Pursuant To Regulation 29 Read With Regulation 47 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015, We Hereby Give Notice That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Tuesday, December 12Th, 2017 Inter-Alia, To Consider And Approve The Unaudited Financial Results (Standalone) For The Second Quarter Ended 30Th September, 2017. Further , It Is Informed That As Per Company'S Code Of Internal Procedures And Conduct For Regulating, Monitoring And Reporting By Insiders Framed Pursuant To The SEBI (Prohibition Of Insider Trading) Regulations, 2015 The Trading Window For Dealing In The Securities Of The Company Shall Remain Closed From Tuesday, December 5Th, 2017 To Monday, 18Th, 2017. (Both Days Inclusive). This Information Is Also Be Available On The Company'S Website At Www.Jagsonpal.Com And On The Website Of BSE And NSE, Where The Company'S Equity Shares Are Listed.

• Security Code: 507789
• Company: JAGSNPHARM

Pursuant to Regulation 29 read with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby give notice that the meeting of the Board of Directors of the company is scheduled to be held on Tuesday, December 12th, 2017 inter-alia, to consider and approve the Unaudited Financial Results (Standalone) for the second quarter ended 30th September, 2017.

Further , it is Informed that as per Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting by Insiders framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Trading window for dealing in the securities of the Company shall remain closed from Tuesday, December 5th, 2017 to Monday, 18th, 2017. (both days inclusive).

This information is also be available on the Company's website at www.jagsonpal.com and on the website of BSE and NSE, where the Company's Equity Shares are listed.